Latest News and Press Releases
Want to stay updated on the latest news?
-
PASADENA, CALIF, July 08, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a...
-
Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The "Canada Pharmaceutical Market Size, Share & Trends Analysis Report by Drug Type, Product (Branded), Type (Prescription, OTC), Disease (Cancer),...
-
PASADENA, CALIF, July 02, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a...
-
Annamycin aims to eliminate cardiotoxicity associated with anthracyclines used to treat about 60% of all children with cancer FDA recommends inclusion of patients as young as 6 months – younger than...
-
Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Sales Outsourcing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
-
Access the on-demand webcast here HOUSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad...
-
Annamycin delivering better performance 7th line than would be expected even in 2nd line for monotherapy Responders (Stable Disease or Partial Response) after 2 cycles of Annamycin showed...
-
Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Kedbumin Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ResearchAndMarkets.com's...
-
Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Abrysvo or Arexvy Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
-
Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Carvykti Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ResearchAndMarkets.com's...